Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-EN Version v15-EN
Language English English
Date Updated 2023-07-13 2023-07-13
Drug Identification Number 00402249 00402249
Brand name SODIUM CHLORIDE BACTERIOSTATIC INJ SODIUM CHLORIDE BACTERIOSTATIC INJ
Common or Proper name Sodium Chloride Bacteriostatic For Injection USP Sodium Chloride Bacteriostatic For Injection USP
Company Name OMEGA LABORATORIES LIMITED OMEGA LABORATORIES LIMITED
Ingredients SODIUM CHLORIDE SODIUM CHLORIDE
Strength(s) 9MG 9MG
Dosage form(s) LIQUID LIQUID
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 10 x 30mL vial / fiole 10 x 30mL vial / fiole
ATC code V07AB V07AB
ATC description ALL OTHER NON-THERAPEUTIC PRODUCTS ALL OTHER NON-THERAPEUTIC PRODUCTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2023-06-29 2023-06-29
Estimated end date 2023-07-21 2023-07-21
Actual end date 2023-07-12 2023-07-12
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Shortage resolved July 12, 2023 Shortage resolved July 12, 2023
Health Canada comments